For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Lack of timely and appropriate follow-up of abnormal test results by GP breaches the Code - 21HDC02050
Lack of timely and appropriate follow-up of abnormal test results by GP breaches the Code - 21HDC02050

In a report released today, Deputy Health and Disability Commissioner Vanessa Caldwell has found a GP breached the Code of Health and Disability Services Consumers’ Rights (the Code) by failing to take the additional and appropriate follow-up actions after an ECG returned an abnormal result.
The report concerns the care provided to a woman by a locum GP after the woman received a COVID-19 Pfizer Comirnaty vaccine. The woman had a rare genetic disorder and following the vaccine her condition began to deteriorate. She presented at an urgent care clinic, where she was assessed by the locum GP.
An ECG taken at the clinic showed abnormal results, but the woman was discharged home without further investigation by the GP and, sadly, the woman passed away four days later.